Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan;33(1):e13683.
doi: 10.1111/pai.13683. Epub 2021 Nov 2.

Second dose of COVID-19 vaccination in immediate reactions to the first BNT162b2

Jaime S Rosa Duque  1 , Daniel Leung  1 , Elaine Y L Au  2 , Yu-Lung Lau  1
Affiliations
Comment

Second dose of COVID-19 vaccination in immediate reactions to the first BNT162b2

Jaime S Rosa Duque et al. Pediatr Allergy Immunol. 2022 Jan.
No abstract available

Keywords: BNT162b2; COVID-19; allergy; children; hypersensitivity; pediatric; vaccine.

PubMed Disclaimer

Conflict of interest statement

Jaime S Rosa Duque, Daniel Leung, Elaine YL Au, and Yu‐Lung Lau declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
The skin manifestation for participants 1, 2, and 3 (horizontal panels A, B, and C, respectively) after their first dose of BNT162b2 was consistent with generalized urticaria
See this image and copyright information in PMC

Comment on

References

    1. Pouessel G, Tanno LK, Claverie C, et al. Fatal anaphylaxis in children in France: analysis of national data. Pediatr Allergy Immunol. 2018;29(1):101‐104. 10.1111/pai.12828 - DOI - PubMed
    1. Broyles AD, Banerji A, Barmettler S, et al. Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs. J Allergy Clin Immunol Pract. 2020;8(9s):S16‐s116. 10.1016/j.jaip.2020.08.006 - DOI - PubMed
    1. Castells MC, Phillips EJ. Maintaining safety with SARS‐CoV‐2 vaccines. N Engl J Med. 2021;384(7):643‐649. 10.1056/NEJMra2035343 - DOI - PMC - PubMed
    1. Krantz MS, Kwah JH, Stone CA, Jr. , et al. Safety evaluation of the second dose of messenger RNA COVID‐19 vaccines in patients with immediate reactions to the first dose. JAMA Intern Med. 2021;e213779. 10.1001/jamainternmed.2021.3779. Epub ahead of print. - DOI - PMC - PubMed
    1. Department of Health, the Government of Hong Kong Safety monitoring of COVID‐19 vaccines in Hong Kong. https://www.drugoffice.gov.hk/eps/do/en/doc/Safety_Monitoring_of_COVID‐1.... Accessed October 8, 2021.